 - If HIV-1-infected, documented current prescription of efavirenz EFV 2 nucleoside reverse transcriptase inhibitor NRTI regimen and reports taking regimen for at least two weeks prior to enrollment regimens containing protease, integrase, or entry inhibitors are not permitted 